Leuprolide in Treating Adults With Hypogonadotropism
Completed · Not applicable
Conditions studied: Hypogonadism
In brief
RATIONALE: Hypogonadotropism is an abnormal condition caused by decreased production of gonadotropins, a group of hormones that stimulate the parts of the reproductive system that produce and release eggs from the ovaries or sperm from the testicles. Leuprolide may stimulate the production of gonadotropins and be effective in increasing testosterone in men and inducing ovulation in women. PURPOSE: Clinical trial to study the effectiveness of leuprolide in treating adults who have hypogonadotropism.
Key facts
- Study ID
- NCT00004438
- Run by
- University of Chicago
- People needed
- 45
- Starts
- 1997-09-01
- Expected to finish
- 2002-09-01
- Last updated by the study team
- 2015-03-25
Who can join
Age: 18 and older, up to 35. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Chicago Children's Hospital — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.